Business Context and Reporting Period
Company: MiMedx Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 9, 2020 (Event Date)
Subject: Termination of a Material Definitive Agreement (Item 1.02)
Key Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial performance data. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Events
- Agreement in Question: Cooperation Agreement dated May 29, 2019, between MiMedx and the "Prescience Point Parties" (including Prescience Partners, Prescience Point, Prescience Capital, PPCM, and Eiad Asbahi) and "Investor Group Designees."
- Termination Notice: On June 29, 2020, PPCM sent a letter purporting to terminate the Cooperation Agreement, alleging a material breach by MiMedx.
- Company Response: MiMedx disputes the allegations and asserts that the Prescience Point Parties do not have the right to terminate the agreement under its terms.
- Counter-Action: The Prescience Point Parties filed a third amendment to their Schedule 13D (Schedule 13D/A) stating they deem the agreement terminated.
Outlook, Risks, and Contingencies
- Legal Contingency: The Company is continuing to evaluate the Schedule 13D/A and the validity of the purported termination.
- Ownership Stake: As of July 14, 2020, the Prescience Point Parties collectively beneficially owned 7.9% of the Company's outstanding common stock.
- Breakdown of Ownership:
- PPCM: 8,754,403 shares
- Mr. Asbahi: 8,755,335 shares
- Prescience Capital: 7,870,269 shares
- Prescience Partners: 6,024,730 shares
- Prescience Point: 1,845,539 shares
Investor Verification Checklist
- Verify the specific terms of the Cooperation Agreement regarding material breach and termination rights.
- Review the full text of the Schedule 13D/A filed by the Prescience Point Parties for details on their allegations.
- Monitor for any subsequent legal filings or press releases regarding the dispute over the agreement's status.
- Assess the potential impact of the Prescience Point Parties' 7.9% ownership stake on future corporate governance or strategic decisions.